FIXX Annual CFI
$101.33 M
+$64.61 M+175.97%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual cash flow from investing activities is $101.33 million, with the most recent change of +$64.61 million (+175.97%) on December 1, 2023. During the last 3 years, it has fallen by -$103.57 million (-50.55%).FIXX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly CFI
$31.72 M
+$54.48 M+239.33%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly cash flow from investing activities is $31.72 million, with the most recent change of +$54.48 million (+239.33%) on December 1, 2023. Over the past year, it has increased by +$54.48 million (+239.33%).FIXX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX TTM CFI
$101.33 M
+$13.72 M+15.67%
01 December 2023
Summary:
As of January 21, 2025, FIXX TTM cash flow from investing activities is $101.33 million, with the most recent change of +$13.72 million (+15.67%) on December 1, 2023. Over the past year, it has increased by +$13.72 million (+15.67%).FIXX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +176.0% | +239.3% | +15.7% |
| 3 y3 years | -50.5% | +239.3% | +15.7% |
| 5 y5 years | +183.2% | +239.3% | +15.7% |
FIXX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -50.5% | -81.2% | -50.5% |
Homology Medicines Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $101.33 M(+176.0%) | $31.72 M(-239.3%) | $101.33 M(+15.7%) |
| Sept 2023 | - | -$22.76 M(-137.3%) | $87.60 M(+3982.1%) |
| June 2023 | - | $61.00 M(+94.4%) | $2.15 M(-102.1%) |
| Mar 2023 | - | $31.37 M(+74.4%) | -$100.22 M(-373.0%) |
| Dec 2022 | $36.72 M(-172.3%) | $17.99 M(-116.6%) | $36.72 M(-41.1%) |
| Sept 2022 | - | -$108.22 M(+161.6%) | $62.39 M(-64.4%) |
| June 2022 | - | -$41.37 M(-124.6%) | $175.13 M(-13.6%) |
| Mar 2022 | - | $168.31 M(+285.5%) | $202.76 M(-499.2%) |
| Dec 2021 | -$50.79 M(-124.8%) | $43.66 M(+865.1%) | -$50.79 M(-46.8%) |
| Sept 2021 | - | $4.52 M(-132.9%) | -$95.40 M(+56.2%) |
| June 2021 | - | -$13.74 M(-83.9%) | -$61.08 M(-1409.7%) |
| Mar 2021 | - | -$85.23 M(+8825.1%) | $4.66 M(-97.7%) |
| Dec 2020 | $204.90 M | -$955.00 K(-102.5%) | $204.90 M(+10.3%) |
| Sept 2020 | - | $38.84 M(-25.3%) | $185.82 M(+38.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $52.01 M(-54.8%) | $133.84 M(+207.5%) |
| Mar 2020 | - | $115.00 M(-674.2%) | $43.53 M(-184.0%) |
| Dec 2019 | -$51.80 M(-57.5%) | -$20.03 M(+52.4%) | -$51.80 M(+140.1%) |
| Sept 2019 | - | -$13.14 M(-65.7%) | -$21.57 M(-59.8%) |
| June 2019 | - | -$38.30 M(-294.8%) | -$53.69 M(-50.6%) |
| Mar 2019 | - | $19.67 M(+92.8%) | -$108.76 M(-10.7%) |
| Dec 2018 | -$121.79 M(+49.4%) | $10.20 M(-122.5%) | -$121.79 M(-42.5%) |
| Sept 2018 | - | -$45.26 M(-51.5%) | -$211.89 M(+26.9%) |
| June 2018 | - | -$93.37 M(-1506.2%) | -$166.94 M(+125.5%) |
| Mar 2018 | - | $6.64 M(-108.3%) | -$74.04 M(-9.2%) |
| Dec 2017 | -$81.53 M(+3498.9%) | -$79.90 M(>+9900.0%) | -$81.53 M(+4928.7%) |
| Sept 2017 | - | -$299.50 K(-36.7%) | -$1.62 M(+22.7%) |
| June 2017 | - | -$473.30 K(-44.2%) | -$1.32 M(+55.8%) |
| Mar 2017 | - | -$848.40 K | -$848.40 K |
| Dec 2016 | -$2.27 M | - | - |
FAQ
- What is Homology Medicines annual cash flow from investing activities?
- What is the all time high annual CFI for Homology Medicines?
- What is Homology Medicines annual CFI year-on-year change?
- What is Homology Medicines quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Homology Medicines?
- What is Homology Medicines quarterly CFI year-on-year change?
- What is Homology Medicines TTM cash flow from investing activities?
- What is the all time high TTM CFI for Homology Medicines?
- What is Homology Medicines TTM CFI year-on-year change?
What is Homology Medicines annual cash flow from investing activities?
The current annual CFI of FIXX is $101.33 M
What is the all time high annual CFI for Homology Medicines?
Homology Medicines all-time high annual cash flow from investing activities is $204.90 M
What is Homology Medicines annual CFI year-on-year change?
Over the past year, FIXX annual cash flow from investing activities has changed by +$64.61 M (+175.97%)
What is Homology Medicines quarterly cash flow from investing activities?
The current quarterly CFI of FIXX is $31.72 M
What is the all time high quarterly CFI for Homology Medicines?
Homology Medicines all-time high quarterly cash flow from investing activities is $168.31 M
What is Homology Medicines quarterly CFI year-on-year change?
Over the past year, FIXX quarterly cash flow from investing activities has changed by +$54.48 M (+239.33%)
What is Homology Medicines TTM cash flow from investing activities?
The current TTM CFI of FIXX is $101.33 M
What is the all time high TTM CFI for Homology Medicines?
Homology Medicines all-time high TTM cash flow from investing activities is $204.90 M
What is Homology Medicines TTM CFI year-on-year change?
Over the past year, FIXX TTM cash flow from investing activities has changed by +$13.72 M (+15.67%)